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Abstract The active site of the enzymatic omponent (Ia)of the Significant homologies have been found in the amino acid 
Clostridium perfringens iota toxin has been studied by site- sequences of toxins from groups 1 and 2. However, even 
directed mutagenesis. Sequence alignment showed that Ia and C3 though no sequence homology was detected between the 
enzymes display a segment in their C-terminal part which is two groups of proteins, the secondary and tertiary structures 
homologous to that forming the active domain of pertussis toxin, of the enzymatic domain are conserved [1]. The NAD-binding 
cholera toxin, and Escherichia coli thermolabile toxins. This site is composed of a cavity formed by an ct-helix bent over a 
structure consists of a [3-strand and an a-helix which forms the [3-strand. Two amino acids (Glu and His or Arg) that are 
NAD-binding cavity and which is flanked by two catalytic essential for catalysis are located on two [~-strands flanking 
spatially conserved residues involved in catalysis [Domenighini et the NAD-binding cavity in ADP-ribosylating toxins from 
al. (1994) Mol. Microbiol. 14, 41-50]. Substitutions (Arg-295- groups 1 and 2 [1,9]. In the C3 enzyme from C. botulinum 
Lys, Glu-378-Ala, Glu-380-Asp, and Glu-380-Ala) induced a C-003-9 and C. limosum, Glu-173 and Glu-174, respectively, drastic decrease in ADP-ribosylation and cytotoxic activities, 
while substitution of the adjacent Arg (Arg-296-Lys) only have been found to be essential for the ADP-ribosyltransfer- 
partially affected the enzymatic activity and cytotoxicity. These ase activity [10,11]. 
results indicate that Arg-295, Glu-378 and Glu-380 of Ia are Iota toxin is a binary toxin consisting of two independent 
involved in the ADP-ribosylation activity which is essential for protein chains called iota a (Ia) (341- 47 500) and iota b (Ib) 
the morphological changes of cells treated with iota toxin. (Mr 71 500), which are not associated by either covalent or 
non-covalent bonds [12,13]. Ia catalyzes the ADP-ribosylation 
Key words." Iota toxin; Clostridium perfringens; C3 enzyme; of globular skeletal muscle and non-muscle actin at Arg-177 
ADP-ribosylating toxin; C. spiroforme toxin; C. difficile [8,14]. The Ia structural gene encodes a 413 amino acid ma- 
ADP-ribosyltransferase ture protein, and the Ib gene encodes a 836 amino acid pre- 
cursor protein [15,16]. 
In this study, we report first that the enzymatic site is lo- 
1. Introduction cated in the C-terminal moiety of Ia, and then that sequence 
alignment of Ia with other ADP-ribosyltransferases indicates 
ADP-ribosylation is a mechanism widely used by toxins to that Arg-295 and Glu-380 could be two important catalytic 
kill or alter the metabolism of eukaryotic cells. This enzymatic residues. The functional role of Arg-295 and Glu-380 of Ia 
reaction consists in modification of a target protein by trans- was confirmed by site-directed mutagenesis. 
fer of the ADP-ribose (ADPR) moiety from NAD to a spe- 
cific amino acid. The ADP-ribosylating toxins are composed 2. Material and methods 
of two functionally different domains, an enzymatic domain 
(A) and a binding domain (B) which recognizes a cell surface 2.1. Constructions of Ia mutants 
receptor and allows the internalization f subunit A into the Manipulations ofDNA were performed by using standard methods 
cytosol. They can be divided into 4 major groups according to [17]. The PstI-HincII DNA fragment from pMRP67 containing the Ia 
the nature of the target protein. The first group encompasses gene and its own region promoter [15], was snbcloned into the pBlue- 
script SK(-) vector (Stratagene, Montigny-le-Bretonneux, France) to 
diphtheria toxin (DT) and Pseudomonas exotoxin A (PAETA) yield the pMRPl89 recombinant plasmid (Fig. 1). Site-directed mnta- 
that ADP-ribosylates elongation factor 2. A second group genesis was performed by using the Chameleon kit (Stratagene) with 
includes cholera toxin (CT), Escherichia coli heat-labile nter- pMRP189 as template, the Kpnl--* Sr)'I substitution primer (Strata- 
otoxins (LT1 and LT2), pertussis toxin (PT), and Pseudomo- gene), and the appropriate oligonucleotides. The resultant plasmids 
nas exoenzyme S (exoS) that ADP-ribosylate membrane-asso- were subjected to DNA sequencing to confirm the presence of the 
desired mutation. 
ciated G proteins [1]. The third group includes the C3 
enzymes from Clostridium botulinum, C. limosum, Bacillus ce- 2.2. Expression of Ia mutants 
reus and epidermal cell differentiation i hibitor (EDIN) from E. cob TG1 strain carrying the recombinant plasmids were grown 
Staphylococcus aureus which ADP-ribosylate the low molecu- overnight at 37°C with shaking in LB medium [17] containing 100 I.tg 
lar weight GTP-binding protein Rho [2-4]. The target protein of ampicillin per ml. 1 ml of the cell suspension was pelleted in a 
microcentrifuge, r suspended in 100 gl of 10 mM HEPES (pH 7.5), 
of toxins from group 4 is aetin, an ATP-binding protein, and sonicated. The protein contents of the lysates were assayed using 
These toxins include C. botulinum C2 toxin, iota toxin from the BioRad reagent (BioRad, Paris, France). 10 20 gg proteins of 
C. perfringens, C. spiroforme toxin and C. difficile ADP-ribo- bacterial lysates were electrophoresed in a 0.1% SDS-12% polyacryl- 
syltransferase (CDT) [5-8]. amide gel (PAGE). Immunoblotting was performed as previously de- 
scribed [15] by using a 1:400 dilution of immunopurified Ia rabbit 
antibodies [7,18]. Bound antibodies were detected with peroxidase- 
*Corresponding author. Fax: (33) (1) 45 68 84 56. labeled protein A and the chemiluminescence kit provided by Amer- 
E-mail: mpopoff@pasteur.fr sham. 
0014-5793/96/$12.00 © 1996 Federation of European Biochemical Societies. All rights reserved. 
PH S00 1 4-5793(96)0 1 03 5-6 
192 S. Perelle et al./FEBS Letters 395 (1996) 191-194 
Purification of recombinant Ia and Ib was performed as described these two residues are not involved in the enzymatic site of 
previously [12,15]. iota toxin. 
2.3. ADP-ribosylation assays A deletion in the 3' terminal part of Ia gene was con- 
2.3.1. Gel assay. In vitro ADP-ribosylation assays were performed structed by using the HindlII restriction site from pMRP67 
with G actin isolated from Xenopus laevis oocytes as described pre- plasmid. The natural mature protein comprises 413 amino 
viously [15]. The mixture for the PAGE assay (total volume, 20 ~tl) acids [16], whereas the truncated Ia protein encoded by 
contained 7/.tg of oocyte actin, 100 mM HEPES, 5 mM ATP, 2.5 mM 
ADP-ribose, and 5× 105 cpm of [a2p]NAD (spec. act. 30 Ci/mmol; pMRP117 comprises 205 C-terminal residues, pMRP117 
Dupont, NEN Research Products, Boston, MA). Between 1and 10 ~tl showed an immunolabeled protein of 24 kDa corresponding 
of a fraction to be tested for enzymatic activity was added and the to the expected size (24 kDa) plus 27 additional amino acids 
preparation was fractionated by SDS-PAGE and processed by auto- encoded by the vector, which reacted with anti Ia antibodies 
radiography. (Fig. 2). The Ia truncated protein did not show any significant 
2.3.2. Filter assay. The ADP-ribosylation reaction was performed 
as described above, and terminated by the addition of 0.5 ml of tri- ADP-ribosylation activity, as tested by gel assay or filter assay 
chloracetic acid (100%, w/v). The precipitated protein was collected on (Figs. 1 and 3), suggesting that the enzymatic domain is loca- 
a Whatman GF/C glass filter (diameter 2.5 cm). The filter was washed lized on the C-terminal moiety of Ia. 
with 10 ml of trichloracetic acid (10%, w/v) and counted for radio- 
activity. 3.2. Sequence homology between Ia and PT, LT, CT  and C3 
2.4. Culture cell cytotoxicity assay The amino acid sequence of Ia displays low overall homol- 
Cells were cultivated in Dulbecco's modified Eagles medium ogy with other ADP-ribosylating toxins. Ia is more related to 
(DMEM) supplemented with 5% fetal calf bovine serum. Vero (Afri- C3 enzymes (22 to 25% identity) than to the S1 subunit of PT, 
can green monkey kidney) cells were used for cytotoxic assays. Vero and subunits A of LT and CT (15 to 19% identity, respec- 
cells plated into a 96-well Falcon tissue culture plate (Becton Dick- 
inson LabWare, Oxnard, CA) and grown for 24 h to form mono- tively). Pileup alignment of these sequences with the corrected 
layers. Purified Ib (3.3 ktg/ml) was combined with purified Ia (1.7 iota toxin sequence [16] shows that segments of Ia (residues 
I-tg/ml) or bacterial lysates containing wild-type or mutated Ia protein 376-394), C3 (residues 171 187) and EDIN (residues 146-162) 
(1.7 ~tg/ml). Serial 2-fold dilutions in 100 ~tl final volume were added can be aligned with sequences forming the 13-strand and ct- 
to the monolayers. The cells were observed at 18 h after incubation 
for morphological changes, helix structure of PT, LT and CT that constitute the NAD- 
binding cavity (Fig. 4). The Ia and C3 segments are also pre- 
dicted to form 13-strand and c~-helix structures. It is note- 
3. Results and discussion worthy that the amino acids recognized as forming the 13- 
strand of the cavity binding the nicotinamide rings of NAD 
3.1. The enzymatic domain is localized on the C-terminal part in PT, CT and LT [1] are highly conserved in Ia and C3 while 
of Ia those involved in the a-helix are less conserved. The two ami- 
In the first report of the molecular characterization f the no acids (Arg and Glu) flanking the NAD-binding cavity, 
iota toxin, the amino acid sequence alignment of Ia with DT, which have been found to be essential for catalysis in PT, 
PAETA, PT and C3 suggested that Glu-14 and Trp-19 could CT and LT can be aligned with Arg-295 and Glu-380 of Ia 
be part of the active site of Ia [15]. Glu-14 was replaced with and Arg-188 and Glu-173 or Glu-174 of C3 sequences, respec- 
Ala, and Trp-19 with Ser. The mutants howed similar ADP- tively (Fig. 4). This suggests that the spatial arrangement of
ribosylation activity to the wild type (Fig. 1), indicating that the enzymatic site is conserved among these toxins and that 
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Fig. 1. Autoradiogram ofactin ADP-ribosylation i gel assay by wild-type and mutated la proteins (4 ng by reaction): (A) purified Ia (lane l), 
cell extract from E. coli harboring pUC19 (negative control) (lane 2), pMRP67 (lane 3), and pMRP189 (lane 6) (wild-type Ia), and pMRP117 
(C-terminal truncated protein) (lane 4), pMRP297 (E378A) (lane 5), pMRP251 (E380D) (lane 7), pMRP252 (E380A) (lane 8), pMRP260 
(R295K) (lane 9), and pMRP261 (R296K) (lane 10); (B) pBluescript SK (negative control) (lane 1), pMRP189 (wild-type Ia) (lane 2), 
pMRP207 (Wl9S) (lane 3), and pMRP208 (E14A) (lane 4). 
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Fig. 2. Recombinant Ia proteins from E. coli sonic extracts and purified Ia: (A) silver staining SDS-PAGE of purified Ia (0.5 ~tg) (lane 2), and 
45 ixg of total protein from bacterial extract of E. coli carrying pUC19 (negative control) (lane 3), pMRP67 (lane 4), and pMRP189 (lane 6) 
(wild-type Ia), and pMRPI17 (C-terminal truncated protein) (lane 5), pMRP297 (E378A) (lane 7), pMRP251 (E380D) (lane 8), pMRP252 
(E380A) (lane 9), pMRP260 (R295K) (lane 10), and pMRP261 (R296K) (lane 11); molecular mass tandards are shown in lane 1; (B) Western 
blotting of the same samples with anti-Ia antibodies. 
Glu-380 and Arg-295 of Ia should play a key role in the ADP- muscle ADP-ribosyltransferase (rMT) with Asp was accom- 
ribosyltransferase reaction. We have investigated this possibi- panied by a severe reduction of the enzymatic activity [20,21]. 
lity. The biglutamic motif of the iota toxin and related ADP-ribo- 
syltransferase probably participates in NAD binding and in 
3.3. Glu-378, Glu-380 and Arg-295 are involved in the Ia the catalytic reaction. 
ADP-ribosylation site Iota toxin causes usceptible cells to be roundish by disor- 
Glu-380 was replaced by the conservative r sidue Asp (Glu- ganization of the actin cytoskeleton. Actin filaments (F-actin) 
380-Asp) and by the hydrophobic residue Ala (Glu-380-Ala). are polar structures and are in dynamic equilibrium with 
Wild-type Ia and mutated proteins were produced in E. coli, monomeric actin (G-actin). F-Actin polymerizes at one end 
and their yields were determined by silver staining SDS- and depolymerizes at the other end. Ib component mediates 
PAGE and immunoblotting (Fig. 2). Equivalent amounts of the internalization of Ia which ADP-ribosylates G-actin into 
enzymes (4 ng) were used in the gel assay for ADP-ribosyla- the cytosol. Modified G-actin is incorporated at the growing 
tion. Conservative and non-conservative substitutions of Glu- end of F-actin and blocks further polymerization by capping, 
380 induced a pronounced decrease in enzymatic activity (Fig. while depolymerization occurs at the other end of F-actin 
1). The filter assay for ADP-ribosylation performed with 4 ng 
of enzymes indicated that both mutants were over 50-times 30000-1 ~ 
less active than the wild-type toxin. These results indicate that ~. t ~ ~ ~ 1 
Glu-380 is essential for the enzymatic activity of Ia. 
Arg-295 was substituted by the analogous amino acid Lys. 
Since Arg-295 is adjacent to another Arg (Arg-296), the latter 
was also independently replaced by Lys. The Arg-295-Lys ~ 20000 
substitution caused a significant decrease of ADP-ribosylation o 
activity, while that of Arg-296-Lys caused only a slight di- 
minution of activity (Figs. 1 and 3). In the filter assay, the 
proteins with Arg-295-Lys and Arg-296-Lys howed a 96 and 10000 t I I I ~  i 
26% reduction of activity, respectively, compared to the wild- 
type Ia. Theses results indicate clearly that the conserved Arg- 
295 is the functional residue and that the adjacent Arg-296 is ~ ~ ~ ~ 
not involved in the catalytic activity of Ia. 0 
It has recently been shown that NADcanbecross-linked ~- - ,- t° r~ co ~ to t~ o~ °  • ~ r~ o~ ¢~ o r
by UV irradiation to Glu-378 of Ia [19]. The substitution Glu- ~" 
o ~" " 378-Ala induced a drastic decrease in ADP-ribosylation (Figs. O ~ . . . . .  ~" 
1 and 3). Taken together, these results indicate that Glu-378 is ~ "~ ~ ~ ~ '~ CO 
essential for the NAD-binding and the enzymatic activity. The "" CO CO ~ t~ en 
sequence Glu-x-Glu is conserved in a region corresponding to m w O: w w 
that of iota in other ADP-ribosyltransferases such as CT, LT, 
Fig. 3. Quantitative ADP-ribosylation i  filter assay of wild-type 
B. sphoericus mosquitocidal toxin, and mammalian ADP-ri- and mutant Ia proteins. Ia indicates purified wild-type (wt) Ia, num- 
bosyltransferases [19]. The replacement of either Glu-110, or bers denoting the recombinant plasmids ( ee legend to Fig. 2). Con- 
Glu-112 of LT, and either Glu-238 or Glu-240 of the rabbit trol is the ADP-ribosylation assay without Ia protein. 
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Fig. 4. Sequence alignment of Ia with EDIN, C3 from C. botulinum strains C-468 and C-003-9, CT, LT, and PT. [3 (beta strand) and a (alpha 
helix) indicate the conserved structural organization of the NAD binding site. The conserved catalytic residues (E, R) are shown. A vertical bar 
indicates identity between amino acids, ":' denotes homology, and '*' indicates identity with at least another amino acid among the sequence of 
the group. 
leading to the destruction of microfilament etwork [22,23]. In [2] Just, I., Schallehn, G. and Aktories, K. (1992) Biochem. Biophys. 
Res. Commun. 183, 931-936. 
order to determine whether the morphological changes of cells [3] Just, I., Mohr, C., Schallehn, G., Menard, L., Didsbury, J.R,, 
treated with iota toxin are due to the ADP-ribosylation activ- Vandekerckhove, J. Van Damme, J. and Aktories, K. (1992) 
ity, we examined the effects of the la variants in cultured cells. J. Biol. Chem. 267, 10274-10280. 
Vero cells were treated with purified Ib (3.3 ~tg/ml) and wild- [4] Inoue, S., Sugai, M., Murooka, Y., Paik, S.Y., Hong, Y.M,, 
type or mutated Ia (1.7 ~tg/ml). The truncated Ia encoded by Ohgai, H. and Suginaka, H. (1991) Biochem. Biophys. Res. Com- 
pMPR117, and the Glu-378-Ala, Glu-380-Asp, and Glu-380- mun. 174, 459-464. 
[5] Aktories, K., B/irmann, M., Ohishi, I., Tsuyama, S., Jakobs, 
Ala variants howed an above 97% decrease in cytotoxicity of K.H. and Habermann, E. (1986) Nature 322, 390-392. 
the wild-type Ia from pMRP67 and pMRP189. The reduction [6] Popoff, M.R. and Boquet, P. (1988) Biochem. Biophys. Res. 
in cytotoxicity level as a result of the substitution of Arg-295 Commun. 152, 1361-1368. 
with Lys and Arg-296 with Lys was 94 and 25%, respectively. [7] Popoff, M.R., Rubin, E.J., Gill, D.M. and Boquet, P. (1988) 
Infect. Immun. 56, 2299 2306. 
The Glu-14-Ala and Trp-19-Ala variants displayed cytotoxic [8] Simpson, L.L., Stiles, B.G., Zepeda, H.H. and Wilkins, T.D. 
activity similar to that of the wild type. These results provide (1987) Infect. Immun. 55, 118-122. 
further evidence that Vero cell cytotoxieity induced by iota [9] Domenighini, M., Pizza, M. and Rappuoli, R. (1995)in: Bacter- 
toxin is strongly correlated with the actin ADP-ribosylation ial Toxins and Virulence Factors in Disease (Moss, J. et al. eds.) 
pp. 59-80, Dekker, New York. 
activity. [10] Jung, M., Just, I., Van Damme, J., Vandekerckhove, J. and Ak- 
In conclusion, we have shown that Arg-295, Glu-378, and tories, K. (1993) J. Biol. Chem. 268, 23215-23218. 
Glu-380 of Ia are essential for the ADP-ribosylation activity [11] Saito, Y., Nemoto, Y., Ishizaki, T., Watanabe, N., Morii, N. and 
of iota toxin. The sequence alignment suggests that the NAD- Narumiya, S. (1995) FEBS Lett. 371, 105-109. 
binding and catalytic site which has been elucidated in other [12] Stiles, B.G. and Wilkins, T.D. (1986) Infect. Immun. 54, 683-688. 
[13] Stiles, B.G. and Wilkins, T.D. (1986) Toxicon 24, 767 773. 
ADP-ribosylating toxins [1] is conserved in Ia. Arg-295 and [14] Vandekerckhove, J., Schering, B., B/irmann, M. and Aktories, K. 
Glu-380 probably correspond to the two catalytic residues (1987) FEBS Lett. 255, 48-52. 
flanking a 13-strand and s-helix structure which forms the [15] Perelle, S., Gibert, M., Boquet, P. and Popoff, M.R. (1993) In- 
NAD-binding cavity. Glu is conserved in all ADP-ribosylat- fect. Immun. 61, 5147 5156. 
ing toxins, while the second catalytic residue is an Arg in PT, [16] Perelle, S., Gibert, M., Boquet, P. and Popoff, M.R. (1995) In- 
fect. Immun. 63, 4967. 
CT, LT, C3 enzymes, and presumably in Ia, and a His in DT [17] Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular 
and PAETA [1]. A second Glu residue is also involved in the Cloning: A Laboratory Manual, 2nd edn., Cold Spring Harbor 
enzymatic activity in Ia and other ADP-ribosyltransferases Laboratory Press, Cold Spring Harbor, NY. 
such as CT, LT and rMT. [18] Popoff, M.R., Milward, F.W., Bancillon, B. and Boquet, P. 
(1989) Infect. Immun. 57, 2462-2469. 
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